Accession Number: | 0001104659-23-064841 |
Date: | 2023-05-24 |
Issuer: | INTERCEPT PHARMACEUTICALS, INC. (ICPT) |
Original Submission Date: |
ROSA-BJORKESON DAGMAR
C/O INTERCEPT PHARMACEUTICALS, INC.
305 MADISON AVENUE
MORRISTOWN, NJ 07960
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-05-24 | A | 8,111 | a | $0.00 | 26,391 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION TO PURCHASE COMMON STOCK | 9.17 | 2023-05-24 | deemed execution date | A | 12,547 (a) | 2033-05-24 | common stock 12,547 | $9.17 | 12,547 | direct |
ID | footnote |
---|---|
f1 | represents restricted stock units granted to the reporting person. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. all of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the issuer's 2024 annual meeting of stockholders. |
f2 | all of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the issuer's 2024 annual meeting of stockholders. |